Terms: = Lymphoma AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Prognosis
41 results:
1. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients.
Yuan X; Yu T; Zhao J; Jiang H; Hao Y; Lei W; Liang Y; Li B; Qian W
Front Med; 2023 Oct; 17(5):889-906. PubMed ID: 37418076
[TBL] [Abstract] [Full Text] [Related]
3. HIF-1α mediates cxcr4 transcription to activate the AKT/mTOR signaling pathway and augment the viability and migration of activated B cell-like diffuse large B-cell lymphoma cells.
Jin Z; Xiang R; Dai J; Wang Y; Xu Z
Mol Carcinog; 2023 May; 62(5):676-684. PubMed ID: 36789975
[TBL] [Abstract] [Full Text] [Related]
4. Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma.
Jakubikova J; Cholujova D; Beke G; Hideshima T; Klucar L; Leiba M; Jamroziak K; Richardson PG; Kastritis E; Dorfman DM; Anderson KC
JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36752202
[TBL] [Abstract] [Full Text] [Related]
5. Nuclear Medicine Application of Pentixafor/Pentixather Targeting cxcr4 for Imaging and Therapy in Related Disease.
Chen Z; Xue Q; Yao S
Mini Rev Med Chem; 2023; 23(7):787-803. PubMed ID: 36529918
[TBL] [Abstract] [Full Text] [Related]
6. Case report: A rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with KMT2D and MECOM mutations.
Wang L; Tang J; Feng J; Huang Y; Cheng Y; Xu H; Miao Y
Front Immunol; 2022; 13():1001482. PubMed ID: 36325357
[TBL] [Abstract] [Full Text] [Related]
7. Identification of cxcr4 Upregulation in Diffuse Large B-Cell lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics.
Zhang YA; Yang X; Yao J; Ren Y; Liu P
Dis Markers; 2022; 2022():3276925. PubMed ID: 35774848
[TBL] [Abstract] [Full Text] [Related]
8. De Novo CD5-positive diffuse large B-cell lymphoma: A genomic profiling study and prognostic analysis of 46 patients.
Fan Y; Binshen O; Zhang Z; Yi H; Zhang W; Liu Q; Liu Y; Dong L; Wang C
Ann Diagn Pathol; 2022 Jun; 58():151886. PubMed ID: 35255429
[TBL] [Abstract] [Full Text] [Related]
9. Current approach to Waldenström Macroglobulinemia.
Ravi G; Kapoor P
Cancer Treat Res Commun; 2022; 31():100527. PubMed ID: 35149375
[TBL] [Abstract] [Full Text] [Related]
10. Targeting Refractory Mantle Cell lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands.
Kwon D; Takata K; Zhang Z; Chong L; Fraser B; Zeisler J; Miyata-Takata T; Merkens H; Rousseau J; Aoki T; Kuo HT; Tan R; Zhang C; Lau J; Villa D; Uribe CF; Lin KS; Steidl C; Benard F
Clin Cancer Res; 2022 Apr; 28(8):1628-1639. PubMed ID: 35078860
[TBL] [Abstract] [Full Text] [Related]
11. Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma.
Rindler K; Jonak C; Alkon N; Thaler FM; Kurz H; Shaw LE; Stingl G; Weninger W; Halbritter F; Bauer WM; Farlik M; Brunner PM
Mol Cancer; 2021 Sep; 20(1):124. PubMed ID: 34583709
[TBL] [Abstract] [Full Text] [Related]
12. Different chemokine profile between systemic and testicular diffuse large B-cell lymphoma.
Ollikainen RK; Kotkaranta PH; Kemppainen J; Teppo HR; Kuitunen H; Pirinen R; Turpeenniemi-Hujanen T; Kuittinen O; Kuusisto MEL
Leuk Lymphoma; 2021 Sep; 62(9):2151-2160. PubMed ID: 33856274
[TBL] [Abstract] [Full Text] [Related]
13. Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia.
Wang Y; Gali VL; Xu-Monette ZY; Sano D; Thomas SK; Weber DM; Zhu F; Fang X; Deng M; Zhang M; Hagemeister FB; Li Y; Orlowski RZ; Lee HC; Young KH
Neoplasia; 2021 Apr; 23(4):361-374. PubMed ID: 33735664
[TBL] [Abstract] [Full Text] [Related]
14. Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards cxcr4
Falgàs A; Pallarès V; Unzueta U; Núñez Y; Sierra J; Gallardo A; Alba-Castellón L; Mangues MA; Álamo P; Villaverde A; Vázquez E; Mangues R; Casanova I
Int J Nanomedicine; 2021; 16():1869-1888. PubMed ID: 33716502
[TBL] [Abstract] [Full Text] [Related]
15. Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia.
Klintman J; Appleby N; Stamatopoulos B; Ridout K; Eyre TA; Robbe P; Pascua LL; Knight SJL; Dreau H; Cabes M; Popitsch N; Ehinger M; Martín-Subero JI; Campo E; Månsson R; Rossi D; Taylor JC; Vavoulis DV; Schuh A
Blood; 2021 May; 137(20):2800-2816. PubMed ID: 33206936
[TBL] [Abstract] [Full Text] [Related]
16. Monitoring Plasma Cell Dyscrasias With Cell-free DNA Analysis.
Ntanasis-Stathopoulos I; Gavriatopoulou M; Terpos E; Fotiou D; Kastritis E; Dimopoulos MA
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e905-e909. PubMed ID: 32723621
[TBL] [Abstract] [Full Text] [Related]
17. De Novo CD5
Xu Y; Sun W; Li F
Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):e782-e790. PubMed ID: 32694049
[TBL] [Abstract] [Full Text] [Related]
18. Primary Intra-Axial Diffuse Large B-Cell lymphoma in Immunocompetent Patients: Clinical Impact of Molecular Analysis and Histogenetic Evaluation.
Cambruzzi E
World Neurosurg; 2020 Feb; 134():215-220. PubMed ID: 31605845
[TBL] [Abstract] [Full Text] [Related]
19. Single-cell RNA sequencing reveals chemokine self-feeding of myeloma cells promotes extramedullary metastasis.
Geng S; Wang J; Zhang X; Zhang JJ; Wu F; Pang Y; Zhong Y; Wang J; Wang W; Lyu X; Huang Y; Jing H
FEBS Lett; 2020 Feb; 594(3):452-465. PubMed ID: 31561267
[TBL] [Abstract] [Full Text] [Related]
20. cxcr4 and CCR7 Expression in Primary Nodal Diffuse Large B-Cell lymphoma-A Clinical and Immunohistochemical Study.
Du H; Zhang L; Li G; Liu W; Tang W; Zhang H; Luan J; Gao L; Wang X
Am J Med Sci; 2019 Apr; 357(4):302-310. PubMed ID: 30904045
[TBL] [Abstract] [Full Text] [Related]
[Next]
